Synkinesis after facial paralysis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: •Meet the diagnostic criteria for facial paralysis as outlined in both the 2022 Chinese Guidelines for the Diagnosis and Treatment of Idiopathic Facial Nerve Palsy and the Chinese Clinical Guidelines for Neural Repair Therapy in Idiopathic Facial Nerve Palsy (2022 version). (Criteria: a) Acute onset, often with a history of exposure to wind and cold, or a history of viral infection. b) Sudden paralysis of unilateral facial muscles; disappearance or shallowing of the forehead wrinkles on the affected side, inability to close the eyelid, flattening of the nasolabial fold, deviation of the mouth corner, air leakage when puffing the cheeks, food tending to accumulate in the affected buccal cavity; may be accompanied by loss of taste in the anterior two-thirds of the tongue, hyperacusis, and increased lacrimation on the affected side. No other positive neurological signs are present. c) Normal findings on brain CT and MRI scans.), with a disease course of more than 3 months and the presence of synkinesis on the affected side.(Diagnostic criteria for synkinesis: Based on the description of orocular synkinesis by Maria and Kim (Maria C M, Kim J. Individualized management of facial synkinesis based on facial function. Acta Otolaryngol. 2017). •Patients with facial synkinesis assessed as mild or above using the Synkinesis subscore of the Sunnybrook Facial Grading System. •Aged between 18 and 70 years. •Mentally competent, able to express their own opinions clearly, and capable of cooperating with the treatment. •Voluntarily agree to participate in the study and have signed the informed consent form
Exclusion criteria
Exclusion criteria: • Patients with synkinesis caused by idiopathic facial nerve palsy due to trauma to the jaw and neck,head injury,post-tumor surgery,or other causes of facial nerve damage. • Patients with trigeminal neuralgia. • Patients with impaired consciousness. • Patients with severe primary diseases of the cardiovascular,hepatic,renal,pulmonary,and hematopoietic systems that are not effectively controlled. • Patients in pregnancy or the puerperal period. • Patients with a history of needle syncope,facial skin allergies,or infections. • Patients who have taken central muscle relaxants or received nerve or motor point block treatments with botulinum toxin or other agents within the past six months. • Patients who are currently participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sunnybrook Facial Grading System; | — |
Secondary
| Measure | Time frame |
|---|---|
| Facial Disability Index;Facial Nerve Grading System 2.0 (FNGS 2.0);Synkinesis Assessment Questionnaire;Perceived Facial Stiffness;Facial Asymmetry; | — |
Countries
China
Contacts
Hospital of Chengdu University of Traditional Chinese Medicine